Using synthetic biology to make new antibiotics

July 22, 2014

Research at Victoria University of Wellington could lead to a new generation of antibiotics, helping tackle the global issue of 'superbugs' that are resistant to modern medicine.

Led by Mark Calcott, who has just completed his PhD study, under the supervision of Dr David Ackerley, an associate professor in the School of Biological Science, the research is delivering new knowledge about how synthetic biology might be used to counter bacteria that have become resistant to existing antibiotics.

The recently published study defines new ways that microbes, which are used to make some commonly used types of antibiotics, can be reengineered to produce modified forms of the original molecules.

"Part of the problem is that people have historically been careless when using antibiotics, which has, one-by-one, allowed bacteria to build resistance, thrive and multiply. We're smarter now, but at a time when we're running out of options," says Dr Ackerley.

"There is a serious and immediate need for new antibiotics—either we have to develop the next generation or find clever and affordable ways of modifying the ones we currently have," he says.

"The basis of our research is the idea that the microbial machinery (enzymes) that makes a particular antibiotic can be rearranged, to make a different antibiotic that won't recognise. The will still fight infection, and if we can use them in a more targeted way, bacteria won't become resistant so easily."

He says the ultimate goal of the study is to be able to produce high yields of new and affordable that 'superbugs' don't recognise and are not resistant to.

Results have been published by the American Society for Microbiology journal Applied and Environmental Microbiology.

Explore further: Antibiotic-resistant bacteria found in food products for the first time

More information: Biosynthesis of novel pyoverdines by domain substitution in a non-ribosomal peptide synthetase of Pseudomonas aeruginosa. Mark J. Calcott, Jeremy G. Owen, Iain L. Lamont, and David F. Ackerley. Appl. Environ. Microbiol. AEM.01453-14; published ahead of print 11 July 2014, DOI: 10.1128/AEM.01453-14

Related Stories

Antibiotic-resistant pathogens and poultry

June 18, 2014

(Medical Xpress)—With recent headlines about dangerous "superbugs," an outbreak of Salmonella from chicken parts on the West Coast and the announcement by a national restaurant chain that it plans to serve only "antibiotic-free" ...

Britain launching global superbug fight

July 2, 2014

Britain is to lead a global effort to combat antibiotic-resistant superbugs that threaten to knock medicine "back into the dark ages," Prime Minister David Cameron said Wednesday.

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.